| Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients (NCT03141203) | University of Birmingham | 2015-07-13 |
| Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses (NCT02467270) | Takeda | 2015-07-13 |
| TVEC and Preop Radiation for Sarcoma (4 ml Dose) (NCT02453191) | University of Iowa | 2015-07-13 |
| Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma (NCT02478164) | Dana-Farber Cancer Institute | 2015-07-13 |
| Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer (NCT02362451) | National Cancer Institute (NCI) | 2015-07-10 |
| A Rollover Protocol of Dacomitinib For Patients In Japan (NCT02382796) | Pfizer | 2015-07-10 |
| Aspirin for Venous Ulcers: Randomised Trial (AVURT) (NCT02333123) | St George's, University of London | 2015-07-10 |
| Rituximab and Belimumab for Lupus Nephritis (NCT02260934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-09 |
| A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease (NCT02482298) | AstraZeneca | 2015-07-09 |
| Neo-adjuvant Abiraterone Prostate Study (NCT02160353) | Cancer Trials Ireland | 2015-07-09 |
| A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer (NCT02448771) | Dana-Farber Cancer Institute | 2015-07-09 |
| Postoperative Pain Control With Lipossomic Extended Release Bupivacaine (NCT03560362) | University of Tennessee | 2015-07-09 |
| Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia (NCT01003769) | Mayo Clinic | 2015-07-09 |
| Lithium for Suicidal Behavior in Mood Disorders (NCT01928446) | VA Office of Research and Development | 2015-07-08 |
| Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib. (NCT03418558) | Fondazione del Piemonte per l'Oncologia | 2015-07-08 |
| Intratumoral Injections of LL37 for Melanoma (NCT02225366) | M.D. Anderson Cancer Center | 2015-07-08 |
| Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults (NCT02386098) | ViiV Healthcare | 2015-07-08 |
| Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC) (NCT02402764) | H. Lee Moffitt Cancer Center and Research Institute | 2015-07-08 |
| Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension (NCT02279745) | United Therapeutics | 2015-07-08 |
| Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis (NCT02496585) | Memorial Sloan Kettering Cancer Center | 2015-07-08 |
| A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer (NCT02443883) | Eli Lilly and Company | 2015-07-07 |
| Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease (NCT02489344) | Genzyme, a Sanofi Company | 2015-07-07 |
| Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients (NCT04078308) | Royan Institute | 2015-07-06 |
| Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients (NCT02257502) | Hospices Civils de Lyon | 2015-07-06 |
| ARJ C13 Urea Breath Test System (NCT04036838) | ARJ Medical, Inc. | 2015-07-06 |
| A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies (NCT02494986) | Janssen Sciences Ireland UC | 2015-07-06 |
| Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes (NCT02281084) | Celgene | 2015-07-06 |
| Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma (NCT02494700) | M.D. Anderson Cancer Center | 2015-07-06 |
| Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients (NCT02457273) | National Health Research Institutes, Taiwan | 2015-07-04 |
| Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02420847) | M.D. Anderson Cancer Center | 2015-07-03 |
| Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial (NCT02275533) | National Cancer Institute (NCI) | 2015-07-02 |
| An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum (NCT02406027) | Janssen Research & Development, LLC | 2015-07-02 |
| Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation (NCT02388165) | Pfizer | 2015-07-02 |
| Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies (NCT02120157) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-07-02 |
| A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors (NCT02452424) | Daiichi Sankyo | 2015-07-02 |
| An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis (NCT02518620) | Ablynx, a Sanofi company | 2015-07-01 |
| A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence (NCT02334735) | Nina Bhardwaj | 2015-07-01 |
| Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease (NCT02478424) | Rabin Medical Center | 2015-07-01 |
| Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy (NCT02655081) | University of Pittsburgh | 2015-07-01 |
| 18F-FSPG PET/CT for Cancer Patients on Therapy (NCT02599194) | Andrei Iagaru | 2015-07-01 |
| Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients (NCT02850744) | PIQUR Therapeutics AG | 2015-07-01 |
| CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy (NCT02537977) | Shanghai Tongji Hospital, Tongji University School of Medicine | 2015-07-01 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones (NCT02503345) | Allena Pharmaceuticals | 2015-07-01 |
| Quaternary Ammonium Methacryloxy Silicate-containing Acrylic Resin (NCT02525458) | Frank Tay, BDSc (Hons), PhD | 2015-07-01 |
| Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT02464657) | M.D. Anderson Cancer Center | 2015-07-01 |
| Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) (NCT02343939) | Gilead Sciences | 2015-07-01 |
| A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer (NCT02333890) | Ottawa Hospital Research Institute | 2015-07-01 |
| Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy (NCT02517320) | Tanabe Pharma Corporation | 2015-07-01 |
| the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn (NCT02325843) | Sun Yat-sen University | 2015-07-01 |
| Ambrisentan in Single Ventricle (NCT02080637) | Kevin Hill | 2015-07-01 |
| Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study (NCT02508103) | University of North Carolina, Chapel Hill | 2015-07-01 |
| The Study of AZD8529 for Smoking Cessation in Female Smokers (NCT02401022) | National Institute on Drug Abuse (NIDA) | 2015-07-01 |
| Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors (NCT02684318) | Poveda, Andrés, M.D. | 2015-07-01 |
| Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer (NCT02448420) | SOLTI Breast Cancer Research Group | 2015-07-01 |
| Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus (NCT02533570) | Seagen Inc. | 2015-07-01 |
| Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells (NCT02510469) | Hebei Medical University | 2015-07-01 |
| Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study (NCT02540109) | Soterix Medical | 2015-07-01 |
| Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial (NCT02470676) | Hillel Yaffe Medical Center | 2015-07-01 |
| The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR (NCT02493582) | The First People's Hospital of Changzhou | 2015-07-01 |
| Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer (NCT02506790) | N.N. Petrov National Medical Research Center of Oncology | 2015-07-01 |
| Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus (NCT02671162) | Shiraz University of Medical Sciences | 2015-07-01 |
| Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer (NCT03556956) | AB Science | 2015-07-01 |
| Rilpivirine in Virologically Suppressed Adolescents (NCT03033368) | Mahidol University | 2015-07-01 |
| A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi (NCT02481674) | Vaccinex Inc. | 2015-07-01 |
| A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer (NCT02244463) | Dana-Farber Cancer Institute | 2015-07-01 |
| The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo (NCT02457689) | Imperial College London | 2015-07-01 |
| Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine (NCT02246075) | FORUM Pharmaceuticals Inc | 2015-07-01 |
| JET-GBS - Japanese Eculizumab Trial for GBS (NCT02493725) | Chiba University | 2015-07-01 |
| Intrathecal Dexamethasone and Labor Analgesia (NCT02588417) | ahmed elsakka | 2015-07-01 |
| Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease (NCT02560753) | T3D Therapeutics, Inc. | 2015-07-01 |
| Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment (NCT02600299) | National University of Singapore | 2015-07-01 |
| Impact of Neuropsychological Evaluation on Epilepsy Treatment (NCT03202082) | University of South Florida | 2015-07-01 |
| Pilot Herniorrhaphy Study for Postoperative Analgesia (NCT02504580) | Heron Therapeutics | 2015-07-01 |
| rEduction of oXygen After Cardiac arresT: a Pilot Study (NCT02499042) | Monash University | 2015-07-01 |
| Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas (NCT02494804) | The First People's Hospital of Changzhou | 2015-07-01 |
| Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging (NCT01771679) | Stemedica Cell Technologies, Inc. | 2015-07-01 |
| Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects (NCT02509845) | Armata Pharmaceuticals, Inc. | 2015-07-01 |
| Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients (NCT02861157) | 3-C Institute for Social Development | 2015-07-01 |
| Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip (NCT02844764) | VivaTech International, Inc. | 2015-07-01 |
| Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery (NCT02548715) | University of Alberta | 2015-07-01 |
| Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis (NCT02467504) | Peking University People's Hospital | 2015-07-01 |
| Should Colon or Non-colon Originated Lesions be Distinguished? (NCT02939508) | Chinese Medical Association | 2015-07-01 |
| Refeeding Syndrome in Cancer Patients (NCT02534181) | University of Sao Paulo | 2015-07-01 |
| Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide (NCT02815033) | The European Uro-Oncology Group | 2015-07-01 |
| Topical Anesthetic Use In Pessary Management (NCT02380742) | Loyola University | 2015-07-01 |
| Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer (NCT03163979) | Nanjing Medical University | 2015-07-01 |
| Obeticholic Acid in Pediatric Subjects With Biliary Atresia (NCT05321524) | Intercept Pharmaceuticals | 2015-07-01 |
| The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia (NCT02415062) | Inje University | 2015-07-01 |
| Oxytocin Treatment of Alcohol Dependence (NCT02251912) | University of North Carolina, Chapel Hill | 2015-07-01 |
| Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration (NCT02511613) | Ohr Pharmaceutical Inc. | 2015-07-01 |
| Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. (NCT02506777) | N.N. Petrov National Medical Research Center of Oncology | 2015-07-01 |
| Total/Subtotal Colectomy in Ovarian Cancer (NCT02595021) | Shanghai Gynecologic Oncology Group | 2015-07-01 |
| Pilot Trial of Chlorhexidine Gluconate (CHG) Preoperative Skin Preparation (NCT02530554) | Medline Industries | 2015-07-01 |
| Maintaining Suppression of Testosterone With Transdermal Estradiol Gel (NCT02349386) | BHR Pharma, LLC | 2015-07-01 |
| Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients (NCT02864641) | 3-C Institute for Social Development | 2015-07-01 |
| Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma (NCT02137564) | AIDS Malignancy Consortium | 2015-07-01 |
| Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa (NCT02475265) | Massachusetts General Hospital | 2015-07-01 |
| Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis (NCT02949349) | Genovate Biotechnology Co., Ltd., | 2015-07-01 |
| Subcutaneous Testosterone Project (NCT02229617) | University of British Columbia | 2015-07-01 |
| Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis (NCT02426372) | Qu Biologics Inc. | 2015-07-01 |